.svg)
Anand Iyer
Chief Strategy Officer, WellDoc
Anand is a respected global digital health leader—most known for his insights on and experience with technology, strategy, and regulatory policy. Anand has been instrumental in Welldoc’s success and the development of BlueStar®, the first FDA-cleared mobile prescription therapy for adults with type 2 diabetes. Since joining Welldoc in 2008, he has held core leadership positions that included Chief Data Science Officer, President and Chief Operations Officer. In 2013, Anand was named “Maryland Healthcare Innovator of the Year” in the field of mobile health.
“Digital health, when conceived with clinical, scientific and safety rigor, has the potential to help individuals and the care teams they rely on to transform health care, empowering individuals to take an active role in their health and enabling the health ecosystem to shift to prevention and improved health outcomes. This is becoming ever more critical in chronic care. ANDHealth is an excellent example of public private partnership, as a catalyst to accelerate the meaningful adoption of digital health at the national level.”
Andrew Murphy
Director, HealthXL; Strategic Advisor, patientMpower; Strategic Advisor, MedModus; Strategic Advisor, Webdoctor; Director, Medray Group; Partner, Erisbeg Fund; Executive Chairman & Co-Founder, Robotify Labs
Andrew founded Irish digital health company Slainte Healthcare, first disrupting the Irish healthcare revenue cycle market with Claimsure (acq 2015 by Clanwilliam Group), and separately disrupting the medical records market with Vitro, with significant international clients, including across Australia.
Since leaving the company he founded in 2016, Andrew has been heavily involved in Digital Health Data and Advisory company HealthXL, and has also invested in and worked with a number of Irish digital health companies including Webdoctor, patientMpower and MedModus to rapidly scale and internationalise. As a partner in Erisbeg, Andrew leads P/E investments into a range of healthcare and technology focussed companies as well as being the co-founder and Exec Chairman of rapidly growing EdTech SaaS company, Robotify.
“Since I have begun working with Bronwyn and the wider ANDHealth team in 2018, I have been repeatedly struck by the impact ANDHealth has made on the local digital health innovation ecosystem, but also as importantly how that ecosystem is perceived internationally – leading to greater international investor and pharma interest in Victorian/Australian healthcare innovation as a result.”
Aenor Sawyer
Director UC Space Health Program; Director UCSF Skeletal Health Service; Director, Center for Advanced 3D+ Technologies; Associate Professor, Dept Orthopaedic Surgery, University of California, San Francisco (UCSF)
Dr Aenor Sawyer is the Director of the University of California Space Health Program and previously served as the Chief Health Innovation Officer for the Translational Research Institute for Space Health (TRISH), a NASA-funded program. She has more than two decades of experience in development and evaluation of health technologies, telemedicine and remote medical management. She serves as an Advisor to frontline innovation initiatives at UCSF and with external foundations and industry partners.
She is a member of the UCSF IT Governance Committee, Co-Founder and Co-Director of the UCSF Center for Advanced 3D+ Technologies, Co-Founder of the Center for Digital Health Innovation, a UCSF HEALTH HUB board member, and Advisor to UCSF Innovation Ventures Philanthropy Fund (InVent Fund). External roles also include External Advisory Board Member of the Scripps Translational Sciences Institute, MCRI Health Technology Advisory Board, NODE Health Board Member, and prior Associate Editor of Nature’s Digital Medicine Journal. She is also an Advisor to ANDHealth, Center for Advancing Innovation, and IGNITE Social Impact.
“ANDHealth began as a ground-breaking initiative to advance transformative and evidence-based innovation in health technology. While supporting novel and progressive solutions, ANDHealth is anchored by a leadership team and advisory panel comprised of members with deep knowledge in key sectors including in frontline healthcare needs, technology development and successful financial and sustainability strategies. It would be an honour to participate with ANDHealth in this exciting initiative.”
Bill Lucia
Executive Partner, Consonance Capital and HEP fund (former Chairman and CEO of HMS, acquired by Gainwell 2021 US$3.4B)
Bill Lucia is the former Chairman, President and Chief Executive Officer of HMS, a leading healthcare analytics and technology company. He served as CEO from 2009 to 2021 and was named Chairman of the Board of Directors in July 2015. HMS was acquired by Gainwell Technologies, a portfolio company of Veritas Capital, in April 2021. Under Bill’s leadership, HMS grew to $673 million in revenue, serving 500 healthcare payers and 50 government agencies in 40-plus states and 31 of the 38 private health insurers in Australia.
“Having worked to develop the Australian market for HMS, I have been excited about the Australian government's active role in funding the development of the digital health sector. ANDHealth and their leadership team have developed a superior model for incubating start-ups and partnering with creative entrepreneurs who develop tools that will have a significant impact on healthcare systems globally. There is no better time than now to advance digital health and I am proud to work on such an impactful initiative.”
Drew Schiller
CEO & Co-Founder, Validic
Drew is co-founder and CEO at Validic, the leading digital health platform for personal health data. Drew is Board Chair of the Consumer Technology Association (CTA) Health Division and a member of the CTA Executive Board. He also contributes to advancing the industry through CTA policy efforts and involvement with the CTA Health Standards Subdivision.Drew also serves on the Boards for the eHealth Initiative (eHI) and the North Carolina Council for Entrepreneurial Development (CED). Drew served as a Team Member for the Clinical Trials Transformation Institute (CTTI) project Advancing the Use of Mobile Technologies for Data Capture & Improved Clinical Trials. He previously served on the Federal Advisory Committee joint HITPC/HITSC API Task Force on Meaningful Use 3.
“Digital health is seeing a global renaissance, and there is a massive opportunity to improve both quality and access of healthcare globally. ANDHealth is a critical piece of growing the digital health ecosystem, and I am excited to participate in an advisory capacity."
Kate Merton, PhD MBA
Principal, Hicks Cohen, Former SVP Digital Care Delivery, Anthem Inc
Dr Kate Merton has over 15 years of experience working across the healthcare industry, starting in R&D before moving onto roles in Marketing, Business Development, External Alliances, Medical Affairs, Health Outcomes and most recently Disruptive Innovation. During her career Kate has been part of teams that have discovered new drugs and worked to develop and gain approval for blockbuster diabetes products. Kate is passionate about being part of the future of health care where science intersects with the rapid advancements in health care technology.
“I have participated in and supported various ANDHealth events over the last 12 months and enjoy working with entrepreneurs who participate in and are part of the programs. Based upon my experience leading global incubators, advising the development of digital health products and delivering health solutions to market, I believe I have the requisite experience to participate on the IIAC. I am excited to bring my global expertise with US Payers and international healthcare companies to assist entrepreneurs in Australia lead in global markets.”
Ken Cahill
CEO, SilverCloud
Ken Cahill is the CEO and co-founder of SilverCloud Health with offices in Boston, Dublin, and London. SilverCloud is the world’s leading digital mental health platform. It enables the delivery of clinically validated digital therapeutic care programs that are proven to significantly improve clinical outcomes, increase access and scale while reducing costs of care delivery.
“As digital health has truly moved from niche and into the mainstream, the formative years ahead are going to be critical to shaping our industry, from regulatory to commercial models, the creation of the IIAC is an important step in the commercialization of digital health, its market establishment and the long term viability of our industry.”
Lisa Suennen (Chair)
Managing Partner, Venture Valkyrie, LLC, Board Director, HealthXL and Health Reveal, Advisor to Venture Firms Nina Capital, Longitude Capital and Cardeation Capital, the venture fund of the American Heart Association
2018 Rock Health Digital Health Evangelist of the Year, Lisa Suennen, has spent more than 30 years in healthcare as entrepreneur, advisor and venture capitalist. Today she is Leader of Manatt Phelps & Phillips Digital and Technology Practice, as well as Managing Partner of the Manatt Venture Fund.
Lisa spent the last 23 years as a venture investor, most recently leading the GE Ventures healthcare fund; previously she founded the American Heart Association Cardeation Venture Fund and, before that, spent 15 years as a partner with healthcare fund Psilos Group.
“ANDHealth has been a remarkably successful catalyst for the development of digital health companies for years, and thankfully so given the importance of this category during the pandemic. They have also helped companies realize their vision while fostering jobs and economic growth, both in Australia and in the US, as the mature companies expand. I am thrilled to be an engaged supporter of this organization and its leadership.”
